Structure-based maximal affinity model predicts small-molecule druggability
Year: 2007
Type: article
Source: Nature Biotechnology
DOI: 10.1038/nbt1273
Institutions: Amgen (United States), Pfizer (United States)
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: closed
Funder: Pfizer
OpenAlex ID: W2018408116